Search Results 161-170 of 14843 for anti-TNF drugs

  1. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Subjects have received anti-TNF treatment within 60 days before baseline (Visit 2).

  2. Tricyclic antidepressants and tetracyclic antidepressants - Mayo Clinic

    Cyclic antidepressants tend to have more side effects than other antidepressants. But for some people, they may relieve depression when other drugs fail.

  3. Publications - Imad Absah, M.D. - Mayo Clinic

    2012 Sep; 199(3):W367-75. View PubMed; Absah I, Faubion WA Jr. Concomitant therapy with methotrexate and anti-TNF-alpha in pediatric patients with refractory ...

  4. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    ... Anti-TNF therapy within 12 weeks prior to Screening (Visit 1); Anti-CD52 (alemtuzumab) within 6 months prior to Screening (Visit 1). Liver Function Tests ...

  5. Biological therapy for cancer - Mayo Clinic

    Learn about the latest tools, such as gene therapy and cancer vaccines, that use the body's immune system to fight cancer.

  6. Epilepsy - Diagnosis and treatment - Mayo Clinic

    Therapies that stimulate the brain using a device. A ketogenic diet. Medication. Most people with epilepsy can become seizure-free by taking one anti-seizure ...

  7. Antithymocyte Globulin Rabbit (Intravenous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Anti-thymocyte globulin (rabbit) injection is used together with other medicines to prevent and treat the body from rejecting a transplanted ...

  8. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast ...

  9. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    Ongoing or prior treatment with Infliximab or other anti TNF agents. Concomitant immunomodulator therapy is acceptable if on a stable dosing for atleast 4 weeks ...

  10. Central-acting agents - Mayo Clinic

    Drug withdrawal, such as from opioid pain medicines. Hot flashes in menopause. Tourette syndrome. Side effects. Central-acting agents can have ...